Chronic Lymphocytic Leukemia Registry Study - Multicenter Prospective National Study

N/ARecruitingNCT03197259

Fatih Demirkan, MD1,000 enrolled

Overview

A prospective, multicenter national observational study for patients diagnosed as chronic lymphocytic leukemia across 25 centers in Turkey

The purpose of this study is to explore the history and real world management of patients diagnosed with CLL, provide insight into the management of CLL, and evaluate the effectiveness of first, second and subsequent therapeutic strategies employed in both the community and academic settings.

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Chronic Lymphocytic Leukemia Del(17P)

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients diagnosed as CLL * 18 years or older * Able and willing to provide the written informed consent Exclusion Criteria: * Younger than 18 years

Locations (1)

Dokuz Eylum Medical Favulty

Izmir, Turkey (Türkiye)

RECRUITING

Outcomes

Primary Outcomes

First line therapy therapy protocol distrubition

The primary objective is to describe percentage of first line therapy protocols in patients initiated on therapy for CLL in the community and academic setting

Time frame: 36 months

Central Contacts

Fatih Demirkan, Prof

CONTACT

+90 542 515 17 80 fatihdemirkan@yahoo.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.